{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:12:36Z","timestamp":1781089956902,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.compbiomed.2024.108292","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:50:41Z","timestamp":1710316241000},"page":"108292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Network-based analysis identifies potential therapeutic ingredients of Chinese medicines and their mechanisms toward lung cancer"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9045-3287","authenticated-orcid":false,"given":"Mingrui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5377-0652","authenticated-orcid":false,"given":"Guiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5489-3690","authenticated-orcid":false,"given":"Qiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-7696","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2024.108292_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA","volume":"71","author":"Sung","year":"2021","journal-title":"A Cancer J. Clinic."},{"key":"10.1016\/j.compbiomed.2024.108292_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: epidemiology, etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.compbiomed.2024.108292_bib3","article-title":"Earlier diagnosis of lung cancer","volume":"31","author":"Nielsen","year":"2022","journal-title":"Cancer Treat Res. Commun."},{"key":"10.1016\/j.compbiomed.2024.108292_bib4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1200\/JCO.21.01710","article-title":"Patient-centered palliative care for patients with advanced lung cancer","volume":"40","author":"Temel","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.779915","article-title":"Advances in knowledge and management of immune-related adverse events in cancer immunotherapy","volume":"13","author":"Olsen","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib6","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1097\/CM9.0000000000001141","article-title":"Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer","volume":"133","author":"Su","year":"2020","journal-title":"Chinese Med J"},{"key":"10.1016\/j.compbiomed.2024.108292_bib7","article-title":"Immortal time bias-corrected effectiveness of traditional Chinese medicine in non-small cell lung cancer (C-EVID): a prospective cohort study","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113561","article-title":"Immunomodulation of Chinese Herbal Medicines on NK cell populations for cancer therapy: a systematic review","volume":"268","author":"Liu","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/cam4.2108","article-title":"Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science","volume":"8","author":"Xiang","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.compbiomed.2024.108292_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112836","article-title":"Maimendong and Qianjinweijing Tang (Jin formula) suppresses lung cancer by regulation of miR-149-3p","volume":"258","author":"Jiang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117518","article-title":"Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments","volume":"321","author":"Peng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib12","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1039\/D3FO02482B","article-title":"Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease","volume":"14","author":"Wang","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.compbiomed.2024.108292_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154776","article-title":"Ginsenoside Rb(1) for overcoming cisplatin-insensitivity of A549\/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1","volume":"115","author":"Niu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.compbiomed.2024.108292_bib14","article-title":"Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction","volume":"109","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.compbiomed.2024.108292_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2024.108292_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2024.108292_bib17","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3389\/fphar.2019.01664","article-title":"On-label or off-label? Overcoming regulatory and financial barriers to bring repurposed medicines to cancer patients","volume":"10","author":"Verbaanderd","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5524","article-title":"Drug repurposing: misconceptions, challenges, and opportunities for academic researchers","volume":"13","author":"Begley","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.compbiomed.2024.108292_bib19","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1038\/s41598-021-82857-2","article-title":"In silico identification of natural products from Traditional Chinese Medicine for cancer immunotherapy","volume":"11","author":"Cai","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2024.108292_bib20","article-title":"Lung adenocarcinoma-related target gene prediction and drug repositioning","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.csbj.2022.11.037","article-title":"A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer","volume":"21","author":"Zhang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.compbiomed.2024.108292_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2024.108292_bib23","doi-asserted-by":"crossref","first-page":"D1238","DOI":"10.1093\/nar\/gkab1011","article-title":"Hit 2.0: an enhanced platform for herbal ingredients' targets","volume":"50","author":"Yan","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2024.108292_bib24","doi-asserted-by":"crossref","first-page":"D976","DOI":"10.1093\/nar\/gky987","article-title":"ETCM: an encyclopaedia of traditional Chinese medicine","volume":"47","author":"Xu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2024.108292_bib25","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"Stitch 5: augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2024.108292_bib26","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2024.108292_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinformat."},{"key":"10.1016\/j.compbiomed.2024.108292_bib28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.csbj.2022.03.006","article-title":"INPUT: an intelligent network pharmacology platform unique for traditional Chinese medicine","volume":"20","author":"Li","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.compbiomed.2024.108292_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.1257601","article-title":"Disease networks. Uncovering disease-disease relationships through the incomplete interactome","volume":"347","author":"Menche","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2024.108292_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102075","article-title":"Unveiling the mechanisms of nephrotoxicity caused by nephrotoxic compounds using toxicological network analysis","volume":"34","author":"Xi","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.compbiomed.2024.108292_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10331","article-title":"Network-based in silico drug efficacy screening","volume":"7","author":"Guney","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2024.108292_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/343bf260-f6ff-48a2-93b2-3cc79af518a9","article-title":"Going the distance for protein function prediction: a new distance metric for protein interaction networks","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2024.108292_bib33","article-title":"Network medicine framework for identifying drug-repurposing opportunities for COVID-19","volume":"118","author":"Deisy","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiomed.2024.108292_bib34","doi-asserted-by":"crossref","first-page":"bbab373","DOI":"10.1093\/bib\/bbab373","article-title":"Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients","volume":"23","author":"Wang","year":"2022","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2024.108292_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17849\/insm-47-01-31-39.1","article-title":"Random forest","volume":"47","author":"Rigatti","year":"2017","journal-title":"J. Insur. Med."},{"key":"10.1016\/j.compbiomed.2024.108292_bib36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.compbiomed.2024.108292_bib37","doi-asserted-by":"crossref","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","article-title":"RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning","volume":"51","author":"Burley","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2024.108292_bib38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.compbiomed.2024.108292_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2024.108292_bib40","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/acs.jcim.8b00312","article-title":"Evaluation of AutoDock and AutoDock Vina on the CASF-2013 benchmark","volume":"58","author":"Gaillard","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2024.108292_bib41","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.1021\/acs.est.0c03998","article-title":"Probing the mechanism of hepatotoxicity of hexabromocyclododecanes through toxicological network analysis","volume":"54","author":"Dai","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib42","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.7150\/jca.52088","article-title":"Antiproliferative, apoptotic effects and suppression of oxidative stress of quercetin against induced toxicity in lung cancer cells of rats: in vitro and in vivo study","volume":"12","author":"Zhaorigetu","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.compbiomed.2024.108292_bib43","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/bph.15350","article-title":"Quercetin induces p53-independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species-dependent ferroptosis","volume":"178","author":"Wang","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib44","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.compbiomed.2024.108292_bib45","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1038\/s41598-020-65920-2","article-title":"CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p\/MAPK1 axis","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2024.108292_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2184.2003.00267.x","article-title":"Cell cycle and apoptosis","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Prolif."},{"key":"10.1016\/j.compbiomed.2024.108292_bib47","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2024.108292_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1083\/jcb.201103008","article-title":"The Ras protein superfamily: evolutionary tree and role of conserved amino acids","volume":"196","author":"Rojas","year":"2012","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.compbiomed.2024.108292_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117816","article-title":"Novel PI3K\/Akt\/mTOR pathway inhibitors plus radiotherapy: strategy for non-small cell lung cancer with mutant RAS gene","volume":"255","author":"Chen","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.compbiomed.2024.108292_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13402-018-0377-5","article-title":"Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining","volume":"41","author":"Tayou","year":"2018","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib51","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3390\/cancers15061635","article-title":"Treatment strategies for KRAS-mutated non-small-cell lung cancer","volume":"15","author":"O'Sullivan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.compbiomed.2024.108292_bib52","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1038\/s41598-017-06128-9","article-title":"Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations","volume":"7","author":"Rao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2024.108292_bib53","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","article-title":"Targeting the MAPK pathway in KRAS-driven tumors","volume":"37","author":"Drosten","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.compbiomed.2024.108292_bib54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/2159-8290.CD-10-0044","article-title":"C-raf is required for the initiation of lung cancer by K-RasG12D","volume":"1","author":"Karreth","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.compbiomed.2024.108292_bib55","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/1878-0261.13050","article-title":"EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression","volume":"15","author":"Lee","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.compbiomed.2024.108292_bib56","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1080\/21655979.2022.2043099","article-title":"Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.compbiomed.2024.108292_bib57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/mc.23408","article-title":"Quercetin attenuates the proliferation of arsenic-related lung cancer cells via a caspase-dependent DNA damage signaling","volume":"61","author":"Yang","year":"2022","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.compbiomed.2024.108292_bib58","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1080\/21655979.2022.2037372","article-title":"Quercitrin restrains the growth and invasion of lung adenocarcinoma cells by regulating gap junction protein beta 2","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.compbiomed.2024.108292_bib59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbi.2016.07.028","article-title":"Luteolin exerts pro-apoptotic effect and anti-migration effects on A549 lung adenocarcinoma cells through the activation of MEK\/ERK signaling pathway","volume":"257","author":"Meng","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.compbiomed.2024.108292_bib60","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.lfs.2013.10.004","article-title":"Luteolin attenuates TGF-\u03b21-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K\/Akt-NF-\u03baB-Snail pathway","volume":"93","author":"Chen","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.compbiomed.2024.108292_bib61","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.tiv.2011.05.009","article-title":"Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells","volume":"25","author":"Cai","year":"2011","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.compbiomed.2024.108292_bib62","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3892\/or.2016.5336","article-title":"Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells","volume":"37","author":"Lee","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.compbiomed.2024.108292_bib63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/nu9060597","article-title":"Kaempherol and luteolin decrease claudin-2 expression mediated by inhibition of STAT3 in lung adenocarcinoma A549 cells","volume":"9","author":"Sonoki","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.compbiomed.2024.108292_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4062\/biomolther.2021.074","article-title":"Gallic acid hindered lung cancer progression by inducing cell cycle arrest and apoptosis in A549 lung cancer cells via PI3K\/akt pathway","volume":"30","author":"Ko","year":"2022","journal-title":"Biomol. Ther. (Seoul)"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524003767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524003767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T08:17:01Z","timestamp":1713946621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482524003767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":64,"alternative-id":["S0010482524003767"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108292","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network-based analysis identifies potential therapeutic ingredients of Chinese medicines and their mechanisms toward lung cancer","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108292"}}